Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases.

Zou Y, Chen L, Wang X, Chen Y, Hu L, Zeng S, Wang P, Li G, Huang M, Wang L, He S, Li S, Jian L, Zhang S.

J Gastric Cancer. 2019 Mar;19(1):121-131. doi: 10.5230/jgc.2019.19.e9. Epub 2019 Mar 20.

2.

Prognostic significance of neuroendocrine components in gastric carcinomas.

Park JY, Ryu MH, Park YS, Park HJ, Ryoo BY, Kim MG, Yook JH, Kim BS, Kang YK.

Eur J Cancer. 2014 Nov;50(16):2802-9. doi: 10.1016/j.ejca.2014.08.004. Epub 2014 Sep 4.

PMID:
25201164
3.

Neuroendocrine-like differentiation in patients with pancreatic carcinoma.

Tezel E, Nagasaka T, Nomoto S, Sugimoto H, Nakao A.

Cancer. 2000 Dec 1;89(11):2230-6.

PMID:
11147593
4.

Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.

Sainio M, Visakorpi T, Tolonen T, Ilvesaro J, Bova GS.

Pathol Res Pract. 2018 Jun;214(6):848-856. doi: 10.1016/j.prp.2018.04.015. Epub 2018 Apr 26.

PMID:
29728311
5.

Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.

Zhang T, Su D, Mao Z, Guo X, Wang L, Bai L.

Int J Clin Exp Med. 2015 May 15;8(5):7837-42. eCollection 2015.

6.

Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.

Bollito ER, Pacchioni D, Lopez-Beltran A, Volante M, Terrone C, Casetta G, Mari M, DePompa R, Cappia S, Papotti M.

Anal Quant Cytol Histol. 2005 Aug;27(4):218-24.

PMID:
16220833
7.

Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Eren F, Celikel C, Güllüoğlu B.

Pathol Oncol Res. 2004;10(1):47-51. Epub 2004 Mar 18.

8.

Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.

World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.

9.

Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity.

Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I.

Am J Surg Pathol. 2006 Aug;30(8):945-53.

PMID:
16861964
10.

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.

Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G.

Cancer. 2003 May 15;97(10):2487-97.

11.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

12.

[Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].

Xu F, Liu Q, Han F, Xu E, Lai M, Zhao Z.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Jan;45(1):24-30. Chinese.

PMID:
27045237
13.

Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.

Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.

PMID:
9356878
14.

Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.

Liu Y, He J, Xu J, Li J, Jiao Y, Bei D, Hu Y, Chen H, Xiao Q, Ding K.

Oncol Lett. 2017 Apr;13(4):2230-2236. doi: 10.3892/ol.2017.5681. Epub 2017 Feb 7.

15.

[Prognostic factors of lymph node-negative metastasis gastric cancer].

Sun D, Xu H, Huang J.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194. Chinese.

PMID:
28226354
16.

Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer.

Liu Y, Xu J, Jiao Y, Hu Y, Yi C, Li Q, Tong Z, Wang X, Hu L, Xiao Q, Li J, Ding K.

Biomed Res Int. 2014;2014:789575. doi: 10.1155/2014/789575. Epub 2014 Jun 29.

17.

Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients.

Sawaki M, Yokoi K, Nagasaka T, Watanabe R, Kagawa C, Takada H, Sato S, Yamada T, Kikumori T, Imai T, Nakao A.

Surg Today. 2010 Sep;40(9):831-5. doi: 10.1007/s00595-009-4179-2. Epub 2010 Aug 26.

PMID:
20740345
18.

[Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].

Li Y, Xue XW, Luo YF, Wu HW, Chen J, Zhou WX.

Zhonghua Bing Li Xue Za Zhi. 2018 Jul 8;47(7):486-491. doi: 10.3760/cma.j.issn.0529-5807.2018.07.002. Chinese.

PMID:
29996311
19.

Borrmann's type IV gastric cancer: clinicopathologic analysis.

Yokota T, Teshima S, Saito T, Kikuchi S, Kunii Y, Yamauchi H.

Can J Surg. 1999 Oct;42(5):371-6.

20.

Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.

Genitsch V, Zlobec I, Seiler R, Thalmann GN, Fleischmann A.

Int J Mol Sci. 2017 Jul 28;18(8). pii: E1640. doi: 10.3390/ijms18081640.

Supplemental Content

Support Center